Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides

Angewandte Chemie - International Edition

Volumn 46, Issue 18, 2007, Pages 3308-3312

  Peri, Francesco ^a   Granucci, Francesca ^a   Costa, Barbara ^a   Zanoni, Ivan ^a   Marinzi, Chiara ^a   Nicotra, Francesco ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Biological activity; Carbohydrates; Drug design; Immunology; Medicinal chemistry

Indexed keywords

ACTIVATION ANALYSIS; BIOACTIVITY; CARBOHYDRATES; CELLS; IMMUNOLOGY; TOXICITY;

DRUG DESIGN; HYDROXYLAMINO MONOSACCHARIDES; MEDICINAL CHEMISTRY;

LIPIDS;

AMINE; AMINOSUGAR; HYDROXYLAMINE; LIPID A; MONOSACCHARIDE;

ARTICLE; CELL CULTURE; CHEMISTRY; DENDRITIC CELL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; HUMAN; MACROPHAGE ACTIVATION; PHYSIOLOGY; SYNTHESIS;

AMINES; AMINO SUGARS; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HUMANS; HYDROXYLAMINE; LIPID A; MACROPHAGE ACTIVATION; MONOSACCHARIDES;

EID: 34250811448     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200604932     Document Type: Article

References (26)

1. a) J. Cohen, Nature 2002, 420, 885-891;
2. b) D. C. Angus, Crit. Care Med. 2001, 29, 1303-1310.
3. a) R. C. Bone, Chest 1991, 100, 802-808;
4. b) J. E. Parrillo, N. Engl. J. Med. 1993, 328, 1471-1477.
5. a) O. Westphal, O. Lüderitz, Angew. Chem. 1954, 66, 407-417;
6. b) E. T. Rietschel, T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zähringer, U. Seydel, F. Di Padova, M. Schreier, H. Brade, FASEB J. 1994, 8, 217-225.
7. a) U. Seydel, M. Oikawa, K. Fukase, S. Kusumoto, K. Brandenburg, Eur. J. Biochem. 2000, 267, 3032-3039;
8. b) M. G. Netea, M. van Deuren, B. J. Kullberg, J.-M. Cavaillon, J. W. M. van der Meer, Trends Immunol. 2002, 23, 135-139.
9. a) T. Glück, S. M. Opal, Drugs 2004, 64, 837-859;
10. b) W. J. Christ, L. D. Hawkins, D. Lynn, M. D. Lewis, Y. Kishi, Carbohydr.-Based Drug Discovery, 2003, 1, 341-355.
11. An interesting example of a lipid A agonist without a disaccharide structure is compound ER-112022, which contains a phospholipid dimer connected through an acyclic backbone: E. Lien, J. C. Chow, L. D. Hawkins, P. D. McGuinness, K. Miyake, T. Espevik, F. Gusovsky, D. T. Golenbock, J. Biol. Chem. 2001, 276, 1873-1880.
12. a) M. Matsuura, M. Kiso, A. Hasegawa, Infect. Immun. 1999, 6282-6292;
13. b) R. Tamai, Y. Asai, M. Hashimoto, K. Fukase, S. Kusumoto, H. Ispida, M. Kiso, T. Ogawa, Immunology 2003, 110, 66-72.
14. K. Kawasaki, K. Gomi, Y. Kawai, M. Shiozaki, M. Nishijima, J. Endotoxin Res. 2003, 9, 301-307.
15. O. Equils, Y. Maiki, A. M. Shapiro, K. Michelsen, D. Lu, J. Adams, S. Jordan, Clin. Exp. Immunol. 2006, 143, 58-64.
16. F. Peri, C. Marinzi, M. Barath, F. Granucci, M. Urbano, F. Nicotra, Bioorg. Med. Chem. 2006, 14, 190-199.
17. The half-life of 3 is about 12 h at pH 4.5, as assessed by HPLC kinetic analysis.
18. L. Zitvogel, J. Exp. Med. 2002, 195, 9F-14F.
19. F. Granucci, C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, P. Ricciardi-Castagnoli, Nat. Immunol. 2001, 2, 882-888.
20. C. Winzler, P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, P. Ricciardi-Castagnoli, J. Exp. Med. 1997, 185, 317-327.
21. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira, Nature 2000, 408, 740-745.
22. S. Agrawal, A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, B. Pulendran, J. Immunol. 2003, 171, 4984-4989.
23. J. C. Chow, D. W. Young, D. T. Golenbock, W. J. Christ, F. Gusovsky, J. Biol. Chem. 1999, 274, 10 689-10 692.
24. K. Takeda, T. Kaisho, S. Akira, Annu. Rev. Immunol. 2003, 21, 335-376.
25. R. F. Tsuji, K. Hoshino, Y. Noro, N. M. Tsuji, T. Kurokawa, T. Masuda, S. Akira, B. Nowak, Clin. Exp. Allergy 2003, 33, 249-258.
26. F. Y. Tanga, N. Nutile-McMenemy, J. A. DeLeo, Proc. Natl. Acad. Sci. USA 2005, 102, 5856-5861.